Oscar Health, Inc. (NYSE:OSCR) Shares Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. grew its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 270.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 265,031 shares of the company's stock after purchasing an additional 193,512 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned approximately 0.12% of Oscar Health worth $2,425,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the business. Charles Schwab Investment Management Inc. increased its holdings in shares of Oscar Health by 19.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,125,355 shares of the company's stock valued at $6,268,000 after purchasing an additional 182,206 shares in the last quarter. Graham Capital Management L.P. purchased a new stake in Oscar Health in the 3rd quarter valued at about $894,000. Versor Investments LP purchased a new stake in Oscar Health during the third quarter worth about $553,000. Dark Forest Capital Management LP purchased a new stake in Oscar Health during the third quarter worth about $581,000. Finally, Algert Global LLC increased its stake in shares of Oscar Health by 160.1% during the third quarter. Algert Global LLC now owns 147,567 shares of the company's stock worth $822,000 after buying an additional 90,840 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Stock Performance

Shares of OSCR stock traded down $0.44 on Friday, hitting $16.01. 4,683,831 shares of the stock traded hands, compared to its average volume of 3,232,588. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.19 and a quick ratio of 1.19. The company has a market capitalization of $3.68 billion, a PE ratio of -13.34 and a beta of 1.79. Oscar Health, Inc. has a 1-year low of $4.72 and a 1-year high of $18.55. The company's fifty day moving average is $15.25 and its 200 day moving average is $10.82.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, beating the consensus estimate of ($0.74) by $0.08. The business had revenue of $1.43 billion during the quarter, compared to analysts' expectations of $1.43 billion. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The company's quarterly revenue was up 43.9% on a year-over-year basis. During the same quarter last year, the business posted ($1.05) earnings per share. On average, equities research analysts predict that Oscar Health, Inc. will post -0.23 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently issued reports on OSCR. Raymond James initiated coverage on Oscar Health in a report on Friday, March 22nd. They issued an "outperform" rating and a $20.00 price target for the company. TheStreet upgraded Oscar Health from a "d" rating to a "c-" rating in a research report on Wednesday, February 21st. Wells Fargo & Company lifted their price target on Oscar Health from $12.00 to $20.00 and gave the company an "overweight" rating in a report on Thursday, February 15th. Finally, The Goldman Sachs Group boosted their target price on Oscar Health from $8.00 to $16.00 and gave the stock a "neutral" rating in a report on Friday, February 9th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $13.50.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.